Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,191 | 847 | 432 | -444 | -31 |
| Income taxes - deferred | 19 | -46 | -10 | -25 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 70 | N/A |
| Other Working Capital | 398 | 334 | 267 | 41 | 16 |
| Other Operating Activity | -2,339 | -1,545 | -775 | 263 | 0 |
| Operating Cash Flow | $-731 | $-411 | $-86 | $-95 | $-15 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -590,530 | -393,686 | -196,843 | -131,229 | N/A |
| Sale Of Investment | 592,863 | 395,113 | 197,543 | 65,780 | N/A |
| Other Investing Activity | -134 | 173 | 186 | -173 | 0 |
| Investing Cash Flow | $2,198 | $1,599 | $886 | $-65,622 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 67,854 | 25 |
| Other Financing Activity | 0 | 0 | -238 | -2,135 | -5 |
| Financing Cash Flow | $N/A | $N/A | $-238 | $65,719 | $20 |
| Beginning Cash Position | 2 | 2 | 2 | N/A | N/A |
| End Cash Position | 1,470 | 1,191 | 564 | 2 | 6 |
| Net Cash Flow | $1,467 | $1,189 | $562 | $2 | $6 |
| Free Cash Flow | |||||
| Operating Cash Flow | -731 | -411 | -86 | -95 | -15 |
| Free Cash Flow | -731 | -411 | -86 | -95 | -15 |